Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.960
+0.180 (4.76%)
At close: May 30, 2025, 4:00 PM
3.970
+0.010 (0.25%)
After-hours: May 30, 2025, 4:04 PM EDT
Evotec SE Employees
Evotec SE had 4,740 employees as of December 31, 2024. The number of employees decreased by 321 or -6.34% compared to the previous year.
Employees
4,740
Change (1Y)
-321
Growth (1Y)
-6.34%
Revenue / Employee
$179,735
Profits / Employee
-$47,197
Market Cap
1.40B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
EVO News
- 24 days ago - Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments - Accesswire
- 25 days ago - Evotec SE (EVO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment - Accesswire
- 4 weeks ago - Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025 - Accesswire
- 5 weeks ago - Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb - Accesswire
- 6 weeks ago - Evotec SE (EVO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results - Accesswire
- 7 weeks ago - Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025 - Accesswire